Diminazene aceturate exacerbates renal fibrosis after unilateral ureteral obstruction in female mice
Kidney Research and Clinical Practice · 31.03.2023 · 42 (2) · 188-201
DOI: 10.23876/j.krcp.22.033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney Research and Clinical Practice, erschienen am 31.03.2023. Verfasst von Yosep Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, College of Fisheries Sciences, Pukyong National University, Busan, Republic of Korea. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Background
Diminazene aceturate (DIZE), an angiotensin-converting enzyme 2 (ACE2) activator, exerts anti-inflammatory and antifibrotic effects in a variety of human chronic diseases. However, the role of DIZE in kidney fibrosis and the underlying mechanism remain unclear. Therefore, we investigated the effects of DIZE on the progression of renal fibrosis after unilateral ureteral obstruction (UUO), a well-established model of chronic kidney disease.
Methods
C57BL/6 female or male mice were subjected to right UUO. Mice received 15 mg/kg DIZE or vehicle (saline) daily. On the 7th day after UUO, kidneys were collected for analysis of renal fibrosis (α-smooth muscle actin, phosphorylated SMAD3, transforming growth factor (TGF)-β, Masson’s trichrome, and Sirius red staining), inflammation (macrophage infiltration, proinflammatory cytokines/chemokines), apoptosis/necrotic cell death (TUNEL and periodic acid-Schiff staining), and ACE2 activity and messenger RNA (mRNA) expression.
Results
Treatment with DIZE exacerbated renal fibrosis by upregulating the profibrotic TGF-β/SMAD3 pathway, proinflammatory cytokine/chemokines (interleukin [IL]-1β, monocyte chemoattractant protein-1, IL-6, and macrophage inflammatory protein-2) levels, M2 macrophage accumulation (CD206, IL-4, IL-10, and CX3CL1), and apoptotic/necrotic cell death in the obstructed kidneys of female mice but not male mice. However, DIZE treatment had no effect on ACE2 activity or mRNA expression.
Conclusion
DIZE exacerbates UUO-induced renal fibrosis by aggravating tubular damage, apoptosis, and inflammation through independent of Ang (1–7), Ang 2 levels, and ACE2 expression/activity, rather than protecting against renal fibrosis after UUO. DIZE also has powerful effects on recruiting macrophages, including the M2-polarized subtype, in female UUO mice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biotechnology, College of Fisheries Sciences, Pukyong National University, Busan, Republic of Korea.
- Department of Medical Laboratory Science, Dong-Eui Institute of Technology, Busan, Republic of Korea.
Förderung
- National Research Foundation of Korea
Zitieren
APA
Kim, Y., Kim, J., & Han, S. J. (2023). Diminazene aceturate exacerbates renal fibrosis after unilateral ureteral obstruction in female mice. Kidney Research and Clinical Practice, 42(2), 188-201. https://doi.org/10.23876/j.krcp.22.033
Vancouver
Kim Y, Kim J, Han SJ. Diminazene aceturate exacerbates renal fibrosis after unilateral ureteral obstruction in female mice. Kidney Research and Clinical Practice. 2023;42(2):188-201. doi:10.23876/j.krcp.22.033
BibTeX
@article{Kim2023,
author = {Kim, Yosep and Kim, Jongwan and Han, Sang Jun},
title = {Diminazene aceturate exacerbates renal fibrosis after unilateral ureteral obstruction in female mice},
journal = {Kidney Research and Clinical Practice},
year = {2023},
volume = {42},
number = {2},
pages = {188--201},
doi = {10.23876/j.krcp.22.033}
}
EUVIMED